Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Techweek commits to five more years in KC
With more than 5,000 attendees last week in Union Station, Kansas City more than doubled the expected participation in Techweek, a week-long technology conference. In fact, Kansas City performed so well that Techweek is coming back for at least five more years. Techweek CEO Katy Lynch said that the conference was anticipating about 2,500 attendees, but…
Science City at Union Station wins experience award
Science City at Union Station was named one of two worldwide recipients for a prestigious visitor experience award. The EDGIE Award, or Roy L. Shafer Leading Edge Award, for visitor experience was given to Science City last week by the Association of Science-Technology Centers, a nonprofit organization that represents science centers and museums. The award…
OP prescription software firm lands $2.7M
An Overland Park software company recently wrapped up a hefty funding round, according to its founder and CEO. Rx Savings Solutions, a business that works with other companies to manage employees’ monthly medications, secured $2.7 million in funding. Kansas City investors Dan Henry, CEO of NetSpend Corp., and Jeffrey Brown, chairman at StoreFinancial, led the…
LaunchKC winners reflect on ‘massive opportunity’
Once the dust settled on the LaunchKC grant recipient announcement, the champagne bottles popped. Founders from the 10 winning companies — parred down from a list of 500 — had reason to celebrate Friday afternoon between the promise of $50,000 and the chance to land some office space. Of the 10 recipient companies, six come…